biotech
biotech Articles
Biopharmaceutical company Synthorx has filed with the SEC regarding its initial public offering.
Published:
Last Updated:
The October 31 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
Published:
Last Updated:
Biotech company Moderna has filed with the SEC regarding its initial public offering.
Published:
Last Updated:
The demand for drugs to treat erectile dysfunction has risen to meet the needs of an aging population and to help combat disease-related causes.
Published:
Last Updated:
Nektar shares dipped on Tuesday after the company announced that it would be collaborating with Pfizer to evaluate several combination regimens in multiple cancer settings.
Published:
Last Updated:
Regulus Therapeutics shares shot up on Tuesday after the company announced that it had amended and restructured its collaboration and license agreement with Sanofi.
Published:
Last Updated:
Clearside Biomedical shares were halved early on Monday after the firm reported results from its late-stage Sapphire trial.
Published:
Last Updated:
Alkermes shares dropped early on Friday after the company anncounced the results from its most recent meeting with the U.S. Food and Drug Administration.
Published:
Last Updated:
KemPharm shares made a handy gain on Wednesday after the firm announced a new license agreement with KVK Tech for the U.S. commercial rights of its FDA-approved prodrug product, Apadaz.
Published:
Last Updated:
Melinta Therapeutics shares dropped on Monday despite the company announcing positive top-line results from its Phase 3 trial of Baxdela (delafloxacin) for the treatment of adult patients with...
Published:
Last Updated:
Dicerna Pharmaceuticals and Eli Lilly are partnering up in a global licensing and research collaboration focused on the discovery, development and commercialization of potential new medicines in the...
Published:
Last Updated:
Gilead shares retreated on Friday after it reported mixed third-quarter financial results late on Thursday.
Published:
Last Updated:
The October 15 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
Published:
Last Updated:
Alexion Pharmaceuticals reported better-than-expected quarterly results before the markets opened on Wednesday.
Published:
Last Updated:
Biopharmaceutical company Orchard RX is offering more than 13 million shares in an initial public offering valued up to more than $245 million.
Published:
Last Updated: